Literature DB >> 28379437

Sex as a biological variable in response to temozolomide.

Luke Russell1, Chelsea Bolyard1, Yeshavanth Banasavadi-Siddegowda1, Alex Weiss1, Jianying Zhang2, Reena Shakya3, Kimerly Powell4, Balveen Kaur1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28379437      PMCID: PMC5464457          DOI: 10.1093/neuonc/nox040

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  Survival Trends in Elderly Patients with Glioblastoma in the United States: a Population-based Study.

Authors:  Binay Kumar Shah; Amir Bista; Sandhya Sharma
Journal:  Anticancer Res       Date:  2016-09       Impact factor: 2.480

2.  Venerable brain-cancer cell line faces identity crisis.

Authors:  Elie Dolgin
Journal:  Nature       Date:  2016-09-08       Impact factor: 49.962

3.  Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61.

Authors:  Kazuhiko Kurozumi; Jayson Hardcastle; Roopa Thakur; Joshua Shroll; Michal Nowicki; Akihiro Otsuki; E Antonio Chiocca; Balveen Kaur
Journal:  Mol Ther       Date:  2008-06-10       Impact factor: 11.454

4.  Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.

Authors:  Chad G Rusthoven; Matthew Koshy; David J Sher; Douglas E Ney; Laurie E Gaspar; Bernard L Jones; Sana D Karam; Arya Amini; D Ryan Ormond; A Samy Youssef; Brian D Kavanagh
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

5.  Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007.

Authors:  Robert Dubrow; Amy S Darefsky
Journal:  BMC Cancer       Date:  2011-07-29       Impact factor: 4.430

  5 in total
  1 in total

Review 1.  Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.

Authors:  Upasana Sahu; Rolf F Barth; Yoshihiro Otani; Ryan McCormack; Balveen Kaur
Journal:  J Neuropathol Exp Neurol       Date:  2022-04-27       Impact factor: 3.148

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.